PTC Therapeutics, Inc. (PTCT) Net income 2016–2025
PTC Therapeutics, Inc. (PTCT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$682.6MFY2025 · since FY2016: -$142.1M → $682.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $682.6M | +287.9% |
| FY2024 | -$363.3M | +42.0% |
| FY2023 | -$626.6M | -12.1% |
| FY2022 | -$559.0M | -6.7% |
| FY2021 | -$523.9M | -19.6% |
| FY2020 | -$438.2M | -74.2% |
| FY2019 | -$251.6M | -96.4% |
| FY2018 | -$128.1M | -62.1% |
| FY2017 | -$79.0M | +44.4% |
| FY2016 | -$142.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PTCT financial trends
PTCT RevenuePTCT Net marginPTCT Gross profitPTCT Gross marginPTCT Operating incomePTCT Operating marginPTCT Operating cash flowPTCT Free cash flowPTCT Capital expendituresPTCT Return on equityPTCT Stock buybacksPTCT Dividends paidPTCT Total assetsPTCT Total liabilitiesPTCT Shareholders’ equityPTCT overview →